b.petrov
TL2 · Graz
Contributes reviews on supplier material. Based in Graz.
Joined 21 November 2024 · last posted 15h
69 posts, newest first. Showing up to 150.
-
Journal club: semaglutide in MASH, and surrogate endpoints Replied, post #29 · Evidence › Journal club · 27 Jul 2026 · 28 likes SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
-
Asking a follow-up: new topic or new reply? Replied, post #63 · Start Here › How to Ask · 20 Jul 2026 · 0 likes Taking post #62 at face value and following it one step further. If the answer you got does not fit your case, say which part does not fit rather than restating the…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #76 · Access › Insurance & coverage · 15 Jul 2026 · 23 likes Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves…
-
Fasting versus non-fasting and which tests care Replied, post #68 · Clinical › Bloodwork · 12 Jul 2026 · 22 likes Glycaemic markers integrate over different periods. A point glucose and a longer-term marker disagreeing is not a contradiction; it is two different questions.
-
Request: a per-category review queue Replied, post #88 · Meta › Feature requests · 8 Jul 2026 · 1 like Community support: if other people support your request, they can reply with "+1" or "I would use that too". Widely-requested features are prioritised. Noting that I…
-
I have no scientific background — can I still follow the analytics categories? Replied, post #35 · Start Here › Welcome · 8 Jul 2026 · 6 likes The category structure looks heavier than it is. There are twenty top-level categories and you will use three of them. Find those three, mute the rest for a month, and…
-
Washout with a one-week half-life: the arithmetic — does this still hold? Replied, post #36 · Research Methods › N-of-1 designs · 4 Jul 2026 · 0 likes Order effects matter. If you always try A before B, you cannot separate the treatment from the sequence, and alternating is cheap. That matches what I was told, which…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #62 · Practice › Interactions · 11 Jun 2026 · 31 likes Picking up post #61: that is the part I would want checked first. Anything that also slows gut motility compounds the same mechanism. That is a plausibility argument…
-
Reading a home test result without over-claiming Replied, post #54 · Analytics › Home & field testing · 25 May 2026 · 8 likes Precision of home tests: most consumer-accessible devices are not precise to the level people want ("is this 99% pure or 97% pure"). They give a yes/no or a rough…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #4 · Access › Insurance & coverage · 22 May 2026 · 0 likes Nothing here is legal or medical advice, and appeal processes differ enough by jurisdiction and payer that specifics do not transfer.
-
Coming back to: Why I now write the concentration on the vial in marker Replied, post #7 · Practice › Reconstitution · 19 May 2026 · 7 likes That matches what I have seen, for whatever a single anecdote is worth.
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #122 · Devices › Syringes & needles · 15 May 2026 · 3 likes Post #121 is the version of this I will quote in future. One addition. A note on how 0.3 ml versus 0.5 ml gets discussed rather than on 0.3 ml versus 0.5 ml itself: the…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #67 · Sourcing › Logistics · 11 May 2026 · 0 likes Anyone deciding whether a delay is a problem should ask what would change if they waited another week. Usually the answer is nothing. Adding a source would improve this…
-
Official shortage notices and what they authorise Replied, post #22 · Access › Shortages · 26 Apr 2026 · 3 likes Shortage-driven price movement is real and is a separate question from availability.
-
Designing a personal experiment that could change your mind — one year on Replied, post #37 · Research Methods › N-of-1 designs · 24 Apr 2026 · 30 likes Post #34 is right about the mechanism and I think understates the practical bit. Write down what you would accept as evidence that it did not work, before starting.…
-
Why this subcategory is stricter about sourcing than most Replied, post #20 · Compounds › Secretagogues & GH axis · 19 Apr 2026 · 1 like Post #19 is right about the mechanism and I think understates the practical bit. Evidence quality in the secretagogue literature is honestly weaker than in the incretin…
-
Blind submission and why it changes minds — the long version Replied, post #29 · Sourcing › Independent verification · 18 Apr 2026 · 0 likes What I would check first on Blind submission is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a graph.
-
Managing an unplanned gap in supply Replied, post #95 · Access › Shortages · 13 Apr 2026 · 12 likes Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct primary source rather than pharmacy rumors or forum…
-
A calculator that gives a right answer to the wrong question Replied, post #13 · Data & Tools › Calculators · 2 Apr 2026 · 18 likes I read the earlier replies on calculator twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what was said rather…
-
Follow-up: Evidence quality in the secretagogue literature: an honest assessment Replied, post #21 · Compounds › Secretagogues & GH axis · 22 Mar 2026 · 7 likes Storage: these are lyophilised short peptides and are generally reasonably stable dry and considerably less so in solution. Reconstituting only what will be used within…
-
Request: export my own posts — one year on Replied, post #61 · Meta › Feature requests · 19 Mar 2026 · 1 like Where I part company with post #59, and it is a narrow parting. Request from the analytics side: allow a table in a post to be marked as data rather than layout, so it…
-
Liver enzymes drifting down and what that usually means Replied, post #67 · Clinical › Bloodwork · 16 Mar 2026 · 8 likes Practical experience of liver enzymes drifting, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what make…
-
Revisiting: Maintainer handover: how it works Replied, post #42 · Meta › Wiki maintenance · 10 Mar 2026 · 0 likes Building on post #39 rather than restating it. Authority: if you think a page needs input from someone with specific expertise, suggesting that person helps the…
-
Contributing data without breaching anyone's privacy Replied, post #40 · Data & Tools › Datasets · 5 Mar 2026 · 0 likes Where I part company with post #38, and it is a narrow parting. Outliers should be visible in the published data even if excluded from the analysis, with the exclusion…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #116 · Documentation › Wiki requests · 1 Mar 2026 · 4 likes Objections to a request belong in the open, and a request that survives an objection is a stronger page for it. That is what I would do. It may not be what is correct.
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #85 · Clinical › Bloodwork · 24 Feb 2026 · 0 likes A note on how panel gets discussed rather than on panel itself: the confident posts get the replies and the careful ones get ignored, and the careful ones have been…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #27 · Analytics › Mass spectrometry · 12 Feb 2026 · 13 likes Mass accuracy is expressed in parts per million. It is the difference between observed and theoretical mass divided by theoretical mass, multiplied by a million. A…
-
GLP-1 receptor distribution: central and peripheral Replied, post #2 · Pharmacology › Receptor biology · 8 Feb 2026 · 11 likes Amylin receptor signalling: amylin promotes satiety and slows gastric emptying through a receptor distinct from GLP-1. The hypothesis behind combination therapy is two…
-
[2026 update] Reading a supplementary appendix and finding the interesting part Replied, post #10 · Evidence › Trials · 13 Jan 2026 · 10 likes Answering the question post #8 raises rather than the one it answers. One more thing on Reading a supplementary appendix that took me far too long to see: the two…
-
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #12 · Practice › Storage & stability · 10 Jan 2026 · 0 likes Post #9 is right about the mechanism and I think understates the practical bit. What I would check first on peptide is whether the thing being measured moved or whether…
-
Personal import allowances, compared — a second dataset Replied, post #40 · Access › International · 23 Dec 2025 · 2 likes I read post #36 twice before replying, because I had assumed the opposite. Import rules for personal quantities are jurisdiction-specific and change without much…
-
The decimal-point error, and the habit that catches it Replied, post #73 · Practice › Reconstitution · 16 Dec 2025 · 14 likes Post #72 is the version of this I will quote in future. One addition. Preservative effectiveness is tested against a defined microbial challenge under defined…
-
Prescription requirements and telehealth models Replied, post #35 · Sourcing › Regulatory · 27 Nov 2025 · 6 likes Confirming post #32 from a second method, which matters more than confirming it from a second person. The practical version of prescription requirements and telehealth…
-
DXA precision and the least significant change for lean mass Replied, post #24 · Outcomes › Body composition · 27 Nov 2025 · 16 likes Distinguishing three things in the DXA precision discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the recommendation that…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #115 · Start Here › How to Ask · 19 Nov 2025 · 10 likes Avoid "any advice?" at the end. It is so generic that people do not know which part of the post it refers to. Pick the specific part and ask that specific question…
-
Pen dose counters: what a click does and does not guarantee Replied, post #70 · Devices › Pens & autoinjectors · 17 Nov 2025 · 0 likes The instruction leaflet for a licensed pen is a genuinely good technical document and is almost never read past the first page. It answers most of what gets asked here.
-
EMA product information as a primary source Replied, post #55 · Regional › European Union · 11 Nov 2025 · 3 likes Reimbursement is decided nationally and varies substantially between member states for the same authorised product.
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #92 · Compounds › Tirzepatide · 23 Oct 2025 · 2 likes The arithmetic in post #89 is right; the assumption feeding it is the part to check. Checked the SURMOUNT-4 claim against the primary source this morning. It survives,…
-
Angle of injection and whether 90 degrees is always right Replied, post #37 · Practice › Administration · 18 Oct 2025 · 0 likes I read post #33 twice before replying, because I had assumed the opposite. Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #53 · Documentation › Doc review · 7 Sep 2025 · 0 likes What I want from this Promotion criteria thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can check it.
-
Revisiting: Filter needles: when they help and what they cost you Replied, post #52 · Devices › Syringes & needles · 4 Sep 2025 · 2 likes No notes. Posting so the count is not one.
-
Coming back to: Official shortage notices and what they authorise Replied, post #87 · Access › Shortages · 12 Aug 2025 · 0 likes Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long the gap will be and how that affects your condition. Discussing with your…
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #16 · Practice › Storage & stability · 7 Aug 2025 · 3 likes Adding the measurement that post #13 says would settle it. Temperature excursions in transit are common and are not all equal. A few hours warm is a different event…
-
[2026 update] A single out-of-range value on an otherwise normal panel Replied, post #2 · Clinical › Bloodwork · 20 Jul 2025 · 15 likes Keeping your own results in a single table with dates is more useful than any individual result in it, and almost nobody starts early enough. This is where my knowledge…
-
What a documentation review can and cannot tell you Replied, post #37 · Sourcing › Independent verification · 16 Jul 2025 · 31 likes The record shows what was measured. Everything beyond that is inference and this site tries to keep the line visible.
-
Coming back to: When "no data" is the complete and final answer Replied, post #34 · Compounds › Other compounds · 5 Jul 2025 · 0 likes Answering the question post #30 raises rather than the one it answers. Why catalogue breadth is not evidence of anything: a supplier listing 500 compounds does not make…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #127 · Devices › Cold chain · 21 Jun 2025 · 16 likes Confirming post #124 from a second method, which matters more than confirming it from a second person. A parcel sitting in a vehicle or a depot in a hot month is the…
-
Which panel is worth repeating and which is worth ignoring Replied, post #43 · Clinical › Bloodwork · 21 Jun 2025 · 4 likes Nothing in this subcategory is medical advice, and a panel with an unexpected result is precisely the situation where that matters. I am confident about the direction…
-
Criticising the method without criticising the authors — one year on Replied, post #6 · Evidence › Study critique · 12 Jun 2025 · 0 likes That matches what I have seen, for whatever a single anecdote is worth.
-
High-resolution MS on aggregates and what it can see Replied, post #4 · Analytics › Mass spectrometry · 10 Jun 2025 · 0 likes Answering the question post #2 raises rather than the one it answers. High-resolution: I have looked for the primary source twice and failed twice. Either it does not…
-
A claim built entirely on a subgroup analysis Replied, post #17 · Evidence › Study critique · 4 May 2025 · 0 likes Reading rather than answering, but this is the post I would point somebody at.
-
Sequence verification for an obscure compound: how it is done Replied, post #24 · Compounds › Other compounds · 1 May 2025 · 0 likes Right, and stated more narrowly than I would have dared to state it.
-
Second pass at: Pen dose counters: what a click does and does not guarantee Replied, post #25 · Devices › Pens & autoinjectors · 24 Apr 2025 · 19 likes Post #23 put the caveat in the right place and I want to underline it. Disposal of a used pen is a sharps question even where the needle is retracted, and local rules…
-
An emergency department visit, described afterwards Replied, post #10 · Safety › Adverse events · 9 Apr 2025 · 11 likes Taking post #9 at face value and following it one step further. A note on scope: what I am saying about emergency department visit applies to the case in the first post…
-
Follow-up: How much fluid is actually needed, and how you would know Replied, post #5 · Nutrition & Training › Hydration & electrolytes · 9 Apr 2025 · 0 likes Vomiting and diarrhoea lose fluid and electrolytes together, and replacing only fluid is what turns a short illness into a longer problem. That is the version I use. It…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #135 · Pharmacology › Receptor biology · 20 Mar 2025 · 0 likes A request rather than an answer: could whoever has the primary source for biased agonism post it? I have seen the claim three times this month and each version had lost…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #76 · Access › International · 3 Mar 2025 · 6 likes Careful with the language on Cross-border purchase within. "Not detected" and "not present" are different findings and the first is a statement about the method.
-
Validating a method you did not develop — does this still hold? Replied, post #14 · Analytics › Method validation · 16 Feb 2025 · 9 likes Same experience here, different supplier, so it is at least not unique to one of them.
-
Distinguishing a deletion sequence by mass alone Replied, post #74 · Analytics › Mass spectrometry · 11 Feb 2025 · 0 likes Deamidation adds approximately one dalton and produces a species that frequently elutes very close to the parent. It is the hardest common impurity to see…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #72 · Sourcing › Regulatory · 27 Jan 2025 · 0 likes Sensible. I would want the same detail before I acted on it either.
-
Individual participant data versus aggregate data Replied, post #16 · Evidence › Meta-analyses · 26 Jan 2025 · 16 likes When trials differ in population, duration and comparator, the pooled estimate answers a question no individual trial asked. That is worth saying before the number is…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #48 · Compounds › Semaglutide · 21 Dec 2024 · 4 likes Offering a way to settle Molecular mass of semaglutide rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference…
-
TB-500 and thymosin beta-4: the fragment versus the protein — does this still hold? Replied, post #19 · Compounds › Repair & healing peptides · 17 Dec 2024 · 0 likes Oral versus injected administration claims for BPC-157: the preclinical work studied injection. Oral claims are common in supplier marketing and poorly supported by…
-
Anaesthesia and elective surgery: the aspiration question — does this still hold? Replied, post #11 · Practice › Interactions · 3 Dec 2024 · 3 likes Nothing to add on the substance. Thank you for taking the question at face value.
-
What we do not know about retatrutide, listed explicitly Replied, post #9 · Compounds › Retatrutide · 1 Dec 2024 · 0 likes Heart rate increased in a dose-dependent way in the phase 2 work. That is not a footnote — it is one of the specific things phase 3 exists to characterise, and it is…
-
Converting between mg/mL and units per dose, both directions Replied, post #102 · Practice › Reconstitution · 24 Nov 2024 · 16 likes Adding the measurement that post #101 says would settle it. Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is…
-
Athletes in weight-category sports: a different risk calculus — a second dataset Replied, post #12 · Clinical › Special populations · 8 Nov 2024 · 0 likes This follows post #11 rather than contradicting it. Post-surgical populations, particularly after procedures affecting the gastrointestinal tract, interact with a…
-
Converting between mg/mL and units per dose, both directions Replied, post #78 · Practice › Reconstitution · 6 Nov 2024 · 21 likes Post #75 is right about the mechanism and I think understates the practical bit. Preservative effectiveness is tested against a defined microbial challenge under…
-
A rising related-substance total over six months: degradation or method drift? Replied, post #14 · Analytics › Impurities & related substances · 28 Aug 2024 · 5 likes The arithmetic in post #11 is right; the assumption feeding it is the part to check. Rising related-substance is a good example of a question where the honest answer is…